SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction José Silva-Cardoso, Aurora Andrade, Dulce Brito, Jorge Ferreira, Cândida Fonseca, Marisa Peres, Fátima Franco, Brenda Moura

Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper José Silva-Cardoso, Cândida Fonseca, Fátima Franco, João Morais, Jorge Ferreira, Dulce Brito

Cardiovascular effects of the angiotensin type 2 receptor Gabriel Faria-Costa, Adelino Leite-Moreira, Tiago Henriques-Coelho